Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Risk Factors and Prognosis of Hyperglycemia Secondary to Pancreatic Surgery

NCT06585046 is registered in ClinicalTrials.gov with Shanghai Changzheng Hospital as lead sponsor.

NCT NCT06585046
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06585046 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Risk Factors and Prognosis of Hyperglycemia Secondary to Pancreatic Surgery
Lead sponsor
Shanghai Changzheng Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2017
Completion date
August 1, 2024
Enrollment
382 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, pancreatic surgey